Skip to content

Drug interactions

Bosentan + Cannabidiol

Severity: Moderate

Bosentan and Cannabidiol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cannabidiol may inhibit CYP2C9 and CYP3A4 and thereby increase bosentan exposure. This could raise the risk of hepatotoxicity, edema and anemia.

What this interaction means in plain words

Bosentan and Cannabidiol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Cannabidiol belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cannabidiol inhibits CYP2C9 and possibly CYP3A4, reducing bosentan metabolism; cannabidiol itself is also hepatotoxic.

What to do

Monitor liver aminotransferases and hemoglobin closely, and reduce bosentan dose if hepatic or other adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Cannabidiol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Cannabidiol?

MediHelp rates the interaction as moderate. Bosentan and Cannabidiol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cannabidiol may inhibit CYP2C9 and CYP3A4 and thereby increase bosentan exposure. This could raise the risk of hepatotoxicity, edema and anemia.

How serious is the interaction between Bosentan and Cannabidiol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver aminotransferases and hemoglobin closely, and reduce bosentan dose if hepatic or other adverse effects emerge.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in